Hepatitis C virus core protein transactivates the inducible nitric oxide synthase promoter via NF-κB activation

被引:19
作者
de Lucas, S [1 ]
Bartolomé, J [1 ]
Amaro, MJ [1 ]
Carreño, V [1 ]
机构
[1] Fdn Estudio Hepatit Virales, Madrid 28015, Spain
关键词
HCV core protein; nitric oxide; NF-kappa B;
D O I
10.1016/j.antiviral.2003.08.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Intrahepatic levels of the inducible nitric oxide synthase (iNOS) are increased in chronic hepatitis C patients. As iNOS gene promoter contains Nuclear Factor (NF)kappaKB binding sites and hepatitis C virus (HCV) core protein activates NF-kappaB, the aim of this work was to study if HCV core protein transactivates iNOS promoter through NF-kappaB activation. iNOS mRNA and protein were determined by RT-PCR and western blot in HepG2 cells. The effect of HCV core protein on iNOS promoter was assayed by cotransfecting HepG2 cells with the core protein expression plasmid pHCV-Co and p I iNOS-CAT or p2iNOS-CAT plasmids. Formation of NF-kappaB-DNA complexes was determined by electrophoretic mobility shift assay. Transfection of HepG2 cells with pHCV-Co plasmid results in an increase in iNOS mRNA and protein levels. Cotransfection with pHCV-Co and pliNOS-CAT or p2iNOS-CAT plasmids results in a transactivation of iNOS promoter, the presence of the proximal NF-kappaB binding site in the promoter being sufficient for the transactivation. Furthermore, the HCV core protein increases the formation of complexes between NF-kappaB and its binding sequence in the iNOS promoter. The expression of the NF-kappaB inhibitor IKB reverts the effect of the HCV core protein on the iNOS promoter. In conclusion, HCV core protein transactivates iNOS gene promoter through NF-kappaB activation. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:117 / 124
页数:8
相关论文
共 41 条
[1]   Hepatitis B virus X protein transactivates the inducible nitric oxide synthase promoter [J].
Amaro, MJ ;
Bartolomé, J ;
Carreño, V .
HEPATOLOGY, 1999, 29 (03) :915-923
[2]   Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines [J].
Amin, AR ;
Patel, RN ;
Thakker, GD ;
Lowenstein, CJ ;
Attur, MG ;
Abramson, SB .
FEBS LETTERS, 1997, 410 (2-3) :259-264
[3]  
ANDUS T, 1991, HEPATOLOGY, V13, P364, DOI 10.1016/0270-9139(91)92454-G
[4]  
CAMELS S, 1997, CANCER RES, V57, P3365
[5]   Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor [J].
Chen, CM ;
You, LR ;
Hwang, LH ;
Lee, YHW .
JOURNAL OF VIROLOGY, 1997, 71 (12) :9417-9426
[6]   Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease [J].
García-Monzón, C ;
Majano, PL ;
Zubia, I ;
Sanz, P ;
Apolinario, A ;
Moreno-Otero, R .
JOURNAL OF HEPATOLOGY, 2000, 32 (02) :331-338
[7]   PATHOGENETIC MECHANISMS OF HEPATOCELLULAR DAMAGE IN CHRONIC HEPATITIS-C VIRUS-INFECTION [J].
GONZALEZPERALTA, RP ;
DAVIS, GL ;
LAU, JYN .
JOURNAL OF HEPATOLOGY, 1994, 21 (02) :255-259
[8]   Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice [J].
Guidotti, LG ;
McClary, H ;
Loudis, JM ;
Chisari, FV .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (07) :1247-1252
[9]  
Hoofnagle JH, 1997, HEPATOLOGY S1, V26, p15S
[10]  
Jaiswal M, 2000, CANCER RES, V60, P184